News tagged with heart rhythm disturbances


Vandetanib in thyroid cancer: No proof of added benefit

Vandetanib (trade name Caprelsa) has been approved in Germany since February 2012 for adult patients suffering from a particular form of aggressive thyroid cancer. The German Institute for Quality and Efficiency in Health ...

Cancer created Nov 09, 2012 | popularity not rated yet | comments 0

New guidelines say no to screening EKGs for low-risk patients

(HealthDay) -- A top U.S. advisory panel has recommended against preventive electrocardiography (EKG) screening for people at low risk of heart disease.

Cardiology created Jul 30, 2012 | popularity not rated yet | comments 0 | with audio podcast

Remote ICD monitoring a 'safe alternative' to conventional follow up

Device management using a home monitoring system with daily telemetry in patients with ICDs (implantable cardioverter defibrilators) is a safe alternative to conventional monitoring and could decrease the number of inappropriate ...

Cardiology created Aug 29, 2011 | popularity not rated yet | comments 0

Atomic structure discovered for a sodium channel that generates electrical signals in living cells

Scientists at the University of Washington (UW) in Seattle have determined the atomic architecture of a sodium channel. The achievement opens new possibilities for molecular medicine researchers around the world in designing ...

Medical research created Jul 13, 2011 | popularity 4.8 / 5 (5) | comments 1 | with audio podcast

Atrial fibrillation: New management approaches for the 'new epidemic' in cardiovascular disease

Despite recent advances in the treatment of heart rhythm disturbances, mortality and morbidity rates associated withy atrial fibrillation (AF) remain "unacceptably high", according to a new report. The report, prepared jointly ...

Cardiology created Jun 26, 2011 | popularity not rated yet | comments 0

Researchers question safety of mist inhalers for delivering common drug for chronic lung disease

People who use a mist inhaler to deliver a drug widely prescribed in more than 55 countries to treat chronic obstructive pulmonary disease (COPD) may be 52 percent more likely to die, new Johns Hopkins-led research suggests.

Diseases, Conditions, Syndromes created Jun 15, 2011 | popularity not rated yet | comments 0 | with audio podcast